Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

EUGIA-NINTEDANIB DIN 02547538

Status: Approved
Holder: EUGIA PHARMA INC.
Molecule: NINTEDANIB (NINTEDANIB ESILATE)

Health Canada record

Active ingredient(s)NINTEDANIB (NINTEDANIB ESILATE) 150 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EX09 NINTEDANIB
Original market date
Current status date09-May-2024
SourceHealth Canada DPD

Establishment licence of the holder

Eugia Pharma Inc. — licence 3-002768, currently licensed, last inspection rating C (2026-02-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing NINTEDANIB (NINTEDANIB ESILATE)

DINProductCompanyFormStrengthStatus
02526891AURO-NINTEDANIBAURO PHARMA INCCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02526905AURO-NINTEDANIBAURO PHARMA INCCapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02547511EUGIA-NINTEDANIBEUGIA PHARMA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02569248GLN-NINTEDANIBGLENMARK PHARMACEUTICALS CANADA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGApproved
02569221GLN-NINTEDANIBGLENMARK PHARMACEUTICALS CANADA INC.CapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGApproved
02540762JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed
02550849JAMP NINTEDANIBJAMP PHARMA CORPORATIONCapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02443066OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 100 MGMarketed
02443074OFEVBOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleNINTEDANIB (NINTEDANIB ESILATE) 150 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
331952024-05-09Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Manufacturers
Request a quote for EUGIA-NINTEDANIB

How to read a Canadian DIN record